298 related articles for article (PubMed ID: 9166424)
1. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
J Exp Med; 1997 Jun; 185(11):1951-8. PubMed ID: 9166424
[TBL] [Abstract][Full Text] [Related]
2. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
Infect Immun; 1998 Oct; 66(10):4804-10. PubMed ID: 9746582
[TBL] [Abstract][Full Text] [Related]
3. Identification of S-(2,3-dihydroxypropyl)cystein in a macrophage-activating lipopeptide from Mycoplasma fermentans.
Mühlradt PF; Meyer H; Jansen R
Biochemistry; 1996 Jun; 35(24):7781-6. PubMed ID: 8672478
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of a synthetic 2-kilodalton macrophage-activating lipopeptide of Mycoplasma fermentans after pulmonary application.
Lührmann A; Deiters U; Skokowa J; Hanke M; Gessner JE; Mühlradt PF; Pabst R; Tschernig T
Infect Immun; 2002 Jul; 70(7):3785-92. PubMed ID: 12065522
[TBL] [Abstract][Full Text] [Related]
6. Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.
Piec G; Mirkovitch J; Palacio S; Mühlradt PF; Felix R
Infect Immun; 1999 Dec; 67(12):6281-5. PubMed ID: 10569738
[TBL] [Abstract][Full Text] [Related]
7. Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.
Calcutt MJ; Kim MF; Karpas AB; Mühlradt PF; Wise KS
Infect Immun; 1999 Feb; 67(2):760-71. PubMed ID: 9916088
[TBL] [Abstract][Full Text] [Related]
8. Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6.
Mühlradt PF; Frisch M
Infect Immun; 1994 Sep; 62(9):3801-7. PubMed ID: 8063396
[TBL] [Abstract][Full Text] [Related]
9. Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2.
Kaufmann A; Mühlradt PF; Gemsa D; Sprenger H
Infect Immun; 1999 Dec; 67(12):6303-8. PubMed ID: 10569741
[TBL] [Abstract][Full Text] [Related]
10. In vivo immunomodulation by Mycoplasma fermentans membrane lipoprotein.
Romero F; Moreno E; Ruiz-Bravo A; Jiménez-Valera M
Curr Microbiol; 2004 Mar; 48(3):237-9. PubMed ID: 15057472
[TBL] [Abstract][Full Text] [Related]
11. Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1alpha (MIP-1alpha), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice.
Deiters U; Mühlradt PF
Infect Immun; 1999 Jul; 67(7):3390-8. PubMed ID: 10377117
[TBL] [Abstract][Full Text] [Related]
12. Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2.
Liao D; Su X; Wang J; Yu J; Luo H; Tian W; Ye Z; He J
Front Immunol; 2023; 14():1113715. PubMed ID: 36761746
[No Abstract] [Full Text] [Related]
13. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?
Galanos C; Gumenscheimer M; Mühlradt P; Jirillo E; Freudenberg M
J Endotoxin Res; 2000; 6(6):471-6. PubMed ID: 11521073
[TBL] [Abstract][Full Text] [Related]
14. MDHM, a macrophage-activating product of Mycoplasma fermentans, stimulates murine macrophages to synthesize nitric oxide and become tumoricidal.
Ruschmeyer D; Thude H; Mühlradt PF
FEMS Immunol Med Microbiol; 1993 Oct; 7(3):223-9. PubMed ID: 8275053
[TBL] [Abstract][Full Text] [Related]
15. Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans.
Davis KL; Wise KS
Infect Immun; 2002 Mar; 70(3):1129-35. PubMed ID: 11854192
[TBL] [Abstract][Full Text] [Related]
16. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions.
Nishiguchi M; Matsumoto M; Takao T; Hoshino M; Shimonishi Y; Tsuji S; Begum NA; Takeuchi O; Akira S; Toyoshima K; Seya T
J Immunol; 2001 Feb; 166(4):2610-6. PubMed ID: 11160323
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of Mycoplasma fermentans on tumour necrosis factor (TNF)-alpha-induced apoptosis resides in the membrane lipoproteins.
Gerlic M; Horowitz J; Farkash S; Horowitz S
Cell Microbiol; 2007 Jan; 9(1):142-53. PubMed ID: 16889623
[TBL] [Abstract][Full Text] [Related]
18. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.
Rharbaoui F; Drabner B; Borsutzky S; Winckler U; Morr M; Ensoli B; Mühlradt PF; Guzmán CA
Eur J Immunol; 2002 Oct; 32(10):2857-65. PubMed ID: 12355438
[TBL] [Abstract][Full Text] [Related]
19. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6.
Okusawa T; Fujita M; Nakamura J; Into T; Yasuda M; Yoshimura A; Hara Y; Hasebe A; Golenbock DT; Morita M; Kuroki Y; Ogawa T; Shibata K
Infect Immun; 2004 Mar; 72(3):1657-65. PubMed ID: 14977973
[TBL] [Abstract][Full Text] [Related]
20. Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts.
Fabisiak JP; Gao F; Thomson RG; Strieter RM; Watkins SC; Dauber JH
Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L781-93. PubMed ID: 16751226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
